IL103944A - Piperazine derivatives, their preparation and pharmaceutical compositions containing them - Google Patents

Piperazine derivatives, their preparation and pharmaceutical compositions containing them

Info

Publication number
IL103944A
IL103944A IL103944A IL10394492A IL103944A IL 103944 A IL103944 A IL 103944A IL 103944 A IL103944 A IL 103944A IL 10394492 A IL10394492 A IL 10394492A IL 103944 A IL103944 A IL 103944A
Authority
IL
Israel
Prior art keywords
alkyl
aryl
carbon atoms
heterocyclic ring
radical
Prior art date
Application number
IL103944A
Other languages
English (en)
Other versions
IL103944A0 (en
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Publication of IL103944A0 publication Critical patent/IL103944A0/xx
Publication of IL103944A publication Critical patent/IL103944A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18Ethylenedioxybenzenes, not substituted on the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
IL103944A 1991-12-05 1992-12-02 Piperazine derivatives, their preparation and pharmaceutical compositions containing them IL103944A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919125900A GB9125900D0 (en) 1991-12-05 1991-12-05 Piperazine derivatives

Publications (2)

Publication Number Publication Date
IL103944A0 IL103944A0 (en) 1993-05-13
IL103944A true IL103944A (en) 1997-06-10

Family

ID=10705770

Family Applications (1)

Application Number Title Priority Date Filing Date
IL103944A IL103944A (en) 1991-12-05 1992-12-02 Piperazine derivatives, their preparation and pharmaceutical compositions containing them

Country Status (22)

Country Link
US (1) US5710149A (hu)
EP (1) EP0625977B1 (hu)
JP (1) JP3262333B2 (hu)
KR (1) KR100244626B1 (hu)
AT (1) ATE162527T1 (hu)
AU (1) AU658242B2 (hu)
BR (1) BR9206861A (hu)
CA (1) CA2124680C (hu)
DE (1) DE69224212T2 (hu)
DK (1) DK0625977T3 (hu)
ES (1) ES2111654T3 (hu)
FI (1) FI942635A (hu)
GB (2) GB9125900D0 (hu)
GR (1) GR3025988T3 (hu)
HU (2) HUT70755A (hu)
IL (1) IL103944A (hu)
MX (1) MX9206939A (hu)
NZ (1) NZ246007A (hu)
RU (1) RU2125566C1 (hu)
TW (1) TW306921B (hu)
WO (1) WO1993011122A1 (hu)
ZA (1) ZA929317B (hu)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9300195D0 (en) * 1993-01-06 1993-03-03 Wyeth John & Brother Ltd Piperazine derivatives
US5609849A (en) * 1994-03-11 1997-03-11 The Trustees Of The University Of Pennsylvania Serotonin (5-HT1A) receptor ligands and imaging agents
US5434158A (en) * 1994-04-26 1995-07-18 Merck & Co., Inc. Spiro-substituted azacycles as neurokinin-3 antagonists
GB9419024D0 (en) * 1994-09-21 1994-11-09 Wyeth John & Brother Ltd Bicyclic carboxamides
US5607936A (en) * 1994-09-30 1997-03-04 Merck & Co., Inc. Substituted aryl piperazines as neurokinin antagonists
US5466688A (en) * 1994-10-20 1995-11-14 American Home Products Corporation Pyrido[3,4-B]indole derivatives as serotonergic agents
US5439915A (en) * 1994-10-20 1995-08-08 American Home Products Corporation Pyrido[3,4-B]indole carboxamide derivatives as serotonergic agents
US5451584A (en) * 1994-11-10 1995-09-19 American Home Products Corporation N-alkynyl carboxamides as sertonergic agents
US5541179A (en) * 1995-05-02 1996-07-30 American Home Products Corporation Tropon-2-one piperazine carboxamides as serotonergic agents
US5990114A (en) * 1996-02-28 1999-11-23 Recordati, S.A., Chemical And Pharmaceutical Company Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence
US5610164A (en) * 1996-07-24 1997-03-11 American Home Products Corporation (Thiophen-2-yl)-piperidin or tetrahydropyridin azabicyclocarboxamides
US6482827B1 (en) * 1997-07-10 2002-11-19 Pharmacia & Upjohn S.P.A. Matrix metalloproteinase inhibitors
US6376494B1 (en) 1998-06-15 2002-04-23 American Home Products Corporation Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents
CN1312802A (zh) * 1998-06-15 2001-09-12 美国家用产品公司 作为5-羟色胺能药物的环烷基取代的芳基哌嗪、哌啶和四氢吡啶
PE20001420A1 (es) 1998-12-23 2000-12-18 Pfizer Moduladores de ccr5
US7217714B1 (en) 1998-12-23 2007-05-15 Agouron Pharmaceuticals, Inc. CCR5 modulators
US20060223824A1 (en) * 2000-11-28 2006-10-05 Wyeth Serotonergic agents
US20060287335A1 (en) * 2000-11-28 2006-12-21 Wyeth Serotonergic agents for treating sexual dysfunction
WO2003007956A1 (en) * 2001-07-20 2003-01-30 Psychogenics, Inc. Treatment for attention-deficit hyperactivity disorder
ITMI20021327A1 (it) * 2002-06-14 2003-12-15 Recordati Chem Pharm Nuove ossialchilpiperazine
US20050215561A1 (en) * 2004-03-19 2005-09-29 Krishnendu Ghosh Pharmaceutical dosage forms and compositions
US20070099931A1 (en) * 2004-03-19 2007-05-03 Wyeth Pharmaceutical dosage forms and compositions
PA8626301A1 (es) * 2004-03-19 2006-12-07 Wyeth Wyeth Proceso para preparar derivados de n-aril-piperazina
CN101137648A (zh) * 2005-03-01 2008-03-05 惠氏公司 结晶和非晶4-氰基-n-{(2r)-2-[4-(2,3-二氢-苯并[1,4]二氧杂环己烯-5-基)-哌嗪-1-基]-丙基}-n-吡啶-2-基-苯甲酰胺盐酸盐
US7731940B2 (en) 2006-01-25 2010-06-08 The Regents Of The University Of California Compositions and methods related to serotonin 5-HT1A receptors
US9066903B2 (en) 2006-02-28 2015-06-30 The United States Of America As Represented By The Department Of Veterans Affairs Pharmacological treatment of Parkinson's disease
CA2686547C (en) * 2007-05-14 2015-12-08 Sk Holdings Co., Ltd. Novel carbamoyloxy aryl alkan arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound
US8367676B2 (en) * 2009-06-30 2013-02-05 Astrazeneca Ab 2-carboxamide-7-piperazinyl-benzofuran derivatives 774
US8322764B2 (en) 2010-06-11 2012-12-04 Mag-Lok Tools, Inc. Modular long handled tool component system

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ209876A (en) * 1983-10-17 1988-03-30 Duphar Int Res Piperazines and pharmaceutical compositions
US4788290A (en) * 1987-12-11 1988-11-29 American Home Products Corporation Serotonergic pyrazine derivatives
GB8909209D0 (en) * 1989-04-22 1989-06-07 Wyeth John & Brother Ltd Piperazine derivatives
US5340812A (en) * 1989-04-22 1994-08-23 John Wyeth & Brother, Limited Piperazine derivatives
DD297968A5 (de) * 1989-04-22 1992-01-30 �����@��������@�K@�����������@�������k�� Neue piperazine, ihre herstellung und verwendung in pharmazeutischen mitteln
HU221315B1 (en) * 1989-04-22 2002-09-28 Wyeth John & Brother Ltd Alkyl-substituted piperazine derivatives, pharmaceutical compositions containing them, and process for producing them
US5382583A (en) * 1989-04-22 1995-01-17 John Wyeth & Brother, Limited Piperazine derivatives
US4935511A (en) * 1989-09-26 1990-06-19 Rorer Pharmaceutical Corporation Benzoxazine and benzoxazepine carboxamide 5-HT3 antagonists
GB9022820D0 (en) * 1990-10-19 1990-12-05 Wyeth John & Brother Ltd Piperazine derivatives
GB9022790D0 (en) * 1990-10-19 1990-12-05 Wyeth John & Brother Ltd Piperazine derivatives
FR2670491B1 (fr) * 1990-12-14 1993-02-05 Adir Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les renfermant.
GB9112697D0 (en) * 1991-06-13 1991-07-31 Shell Int Research Biocidal compounds
FR2692264B1 (fr) * 1992-06-12 1994-08-05 Adir Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant.
GB9308725D0 (en) * 1993-04-27 1993-06-09 Wyeth John & Brother Ltd Piperazine derivatives

Also Published As

Publication number Publication date
EP0625977A1 (en) 1994-11-30
HU211518A9 (en) 1995-11-28
JP3262333B2 (ja) 2002-03-04
WO1993011122A1 (en) 1993-06-10
HUT70755A (en) 1995-10-30
FI942635A0 (fi) 1994-06-03
GB9125900D0 (en) 1992-02-05
DE69224212T2 (de) 1998-04-30
EP0625977B1 (en) 1998-01-21
RU94030476A (ru) 1996-04-20
AU658242B2 (en) 1995-04-06
GB9225121D0 (en) 1993-01-20
JPH07501803A (ja) 1995-02-23
DE69224212D1 (de) 1998-02-26
NZ246007A (en) 1995-04-27
TW306921B (hu) 1997-06-01
ATE162527T1 (de) 1998-02-15
BR9206861A (pt) 1995-11-21
GR3025988T3 (en) 1998-04-30
US5710149A (en) 1998-01-20
GB2262093A (en) 1993-06-09
AU2953792A (en) 1993-06-28
IL103944A0 (en) 1993-05-13
KR100244626B1 (ko) 2000-05-01
RU2125566C1 (ru) 1999-01-27
DK0625977T3 (da) 1998-05-04
HU9401686D0 (en) 1994-09-28
FI942635A (fi) 1994-06-03
ZA929317B (en) 1994-06-01
CA2124680C (en) 2004-02-17
MX9206939A (es) 1993-06-01
GB2262093B (en) 1995-06-07
ES2111654T3 (es) 1998-03-16
CA2124680A1 (en) 1993-06-10

Similar Documents

Publication Publication Date Title
IL103944A (en) Piperazine derivatives, their preparation and pharmaceutical compositions containing them
MX9202142A (es) Nuevos derivados de urea, proceso para su preparacion, y composicion farmaceutica que los comprende.
GB9215844D0 (en) Novel compounds
IL102652A0 (en) Indole derivatives,their preparation and pharmaceutical compositions containing them
ES8801808A1 (es) Procedimientopara la preparacion de derivados de 2-oxi-4h-3, 1-ebzoxazin-4-ona
CA2053705A1 (en) Piperazine derivatives
ES8105319A1 (es) Procedimiento de preparacion de derivados pirazolo (1,5-c) quinazolinos y de sus sales de adicion acidas
ZA894399B (en) New derivatives of phenothiazine,their preparation and the compositions which contain them
GR3007498T3 (hu)
NZ234450A (en) Substituted pyrrolo(2,1-b)thiazole derivatives, intermediates and pharmaceutical compositions

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
RH1 Patent not in force